Related Experiment Videos
Parkinsonism associated with interferon alpha therapy for chronic myelogenous leukemia
Pichaya Sarasombath1, Kenneth Sumida, David A Kaku
1UH School of Medicine, 1356 Lusitana St., 7th Fl., Honolulu, HI 96813, USA. spichaya@hotmail.com
Hawaii Medical Journal
|April 23, 2002
Abstract:
A 79 year-old man was treated with Interferon alpha for chronic myelogenous leukemia and developed severe parkinsonism that resolved after Interferon alpha was stopped. Carbidopa-levodopa was associated with early improvement, but discontinuation did not result in worsening of the parkinsonism.